Odendaal et al. (1990)
1616 Odendaal HJ, Pattinson RC, BamR, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol. 1990;76(06):1070-1075
|
Randomized clinical trial |
South Africa |
38 |
23 years |
Not mentioned |
Inclusion: severe preeclampsia between 28 and 34 weeks, or fetal weight between 650 and 1,500 g; exclusion: patients who were started on oral antihypertensives before admission |
Glucocorticoid (12 mg betamethasone/12 hours in 2 doses);Intravenous magnesium sulfate (4 g); intramuscular magnesium sulfate (10g) immediately, followed by another 5 g intramuscular every 4 hours for at least 24 hours); dihydralazine (6.25 mg) |
Initial management similar to intervention, but delivery in 24 to 72 hours after the administration of the glucocorticoid |
Placental abruption, stillbirth, neonatal death |
Cesarean section, renal failure, pregnancy prolongation, birth weight |
Sibai et al. (1994)
1717 Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(03):818-822. Doi: 10.1016/0002-9378(94)90104-x https://doi.org/10.1016/0002-9378(94)901...
|
Randomized clinical trial |
United States |
95 |
22 years |
30 weeks |
Inclusion: severe preeclampsia at 28 to 32 weeks; exclusion: patients with renal disease, insulin-dependent diabetes, connective tissue disease, or obstetric complications such as bleeding, rupture of membranes, multifetal gestation, or preterm labor |
Glucocorticoid (betamethasone 12 mg/24 hours in 2 doses); glucocorticoid was repeated weekly until delivery magnesium sulfate (6 g over 20 minutes, followed by 2 g/h); antihypertensive (hydralazine or oral nifedipine) |
Initial management similar to intervention, but delivery in 48 hours of first dose of glucocorticoid |
Eclampsia, HELLP syndrome, placental abruption, stillbirth, neonatal death, intraventricular hemorrhage, small-for-gestational age newborn |
Cesarean section, pulmonary edema, renal failure, prologation of pregnancy, low Apgar score at five minutes, hyaline membrane disease, birth weight, NICU admission |
Mesbah (2003)
1818 Mesbah EM. Severe preterm preeclampsia: aggressive or expectant management? Med J Cairo Univ. 2003;71(01):175-182
|
Randomized clinical trial |
Egypt |
30 |
24 years |
31 weeks |
Inclusion: severe preeclampsia at 28 to 33 weeks; exclusion: patients with renal disease, insulin-dependent diabetes, connective tissue disease, or obstetric complications such as bleeding, rupture of membranes, or pre-term labor |
Glucocorticoid (dexamethasone 8 mg intramuscular/12 hours); magnesium sulfate; oral antihypertensive (nifedipine); fetal evaluation non-stress test, Doppler evaluation, and ultrasound |
Initial management similar to intervention, but delivery in 48 hours of first dose of glucocorticoid |
Eclampsia, HELLP syndrome, placental abruption, stillbirth, neonatal death, small-for-gestational age newborn |
Cesarean section.renal failure, prolongation of pregnancy, low Apgar score at five minutes, birth weight, NICU admission |
Vigil-de Gracia et al. (2013)
1919 Vigil-De Gracia P, Reyes Tejada O, Calle Miñaca A, Tellez G, Chon VY, Herrarte E, et al. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. AmJ Obstet Gynecol. 2013;209(05):425. e1-425.e8. Doi: 10.1016/j.ajog.2013.08.016 https://doi.org/10.1016/j.ajog.2013.08.0...
|
Randomized clinical trial |
Panama, Guatemala, Peru, Mexico, Ecuador, and Venezuela |
267 |
28 years |
30 weeks |
Inclusion: singleton or twin pregnancy and severe hypertensive disorders at 28 to 33 weeks of gestation; exclusion: < 28 weeks of gestation, eclampsia, HELLP syndrome, preeclampsia with renal failure or pulmonary edema, active vaginal bleeding, ruptured membranes, placenta previa, diabetes mellitus or gestational diabetes, preexisting renal disease or autoimmune disease, major fetal abnormalities, fetal growth restriction, oligohydramnios, and reverse umbilical artery Doppler flow |
Glucocorticoid (dexamethasone 6 mg/12 hours in 4 doses, or betamethasone 12 mg/24 hours); magnesium sulfate (4 g intravenous loading dose followed by 1 g intravenous 24 to 48 hours); antihypertensive (hydralazine, labetalol, or oral nifedipine) |
Initial management similar to intervention, but delivery in 24–72 hours of the admonistration of glucocorticoid |
Maternal death, eclampsia.HELLP syndrome, placental abruption, stillbirth, neonatal death, intraventricular hemorrhage, small-for-gestational age newborn |
Cesarean section, pulmonary edema, renal failure, prolongation of pregnancy, hyaline membrane disease, birth weight, NICU admission |
Oláh et al.
(1993)
2020 Oláh KS, Redman CW, Gee H. Management of severe, early preeclampsia: is conservative management justified? Eur J Obstet Gynecol Reprod Biol. 1993;51(03):175-180. Doi: 10.1016/0028-2243(93)90032-8 https://doi.org/10.1016/0028-2243(93)900...
|
Retrospective non-randomized controlled study |
England |
56 |
23 years |
29 weeks |
Inclusion: blood pressure ≥ 170/110 mmHg plus proteinuria (at least 1+ on qualitative testing), and hyperuricaemia; exclusion: preexisting renal disease or essential hypertension |
Glucocorticoid (2 doses of dexamethasone 12 mg/every 12 hours once a week); antihypertensive (nifedipine, methyldopa, oxprenolol) |
Initial management similar, delivery at 24–48 hours. Antihypertensive. Phenytoin or diazepam. No administration of glucocorticoid |
HELLP syndrome, neonatal death |
Hyaline membrane disease, birth weight |
Sarsam et al. (2008)
2121 Sarsam DS, Shamden M, AlWazan R. Expectant versus aggressive management in severe preeclampsia remote from term. Singapore Med J. 2008;49(09):698-703
|
Prospective non-randomized controlled study |
Iraq |
74 |
Not mentioned |
29weeks |
Inclusion: singleton pregnancies at 24 and 34 weeks, complicated by severe preeclampsia; exclusion: failure to control blood pressure, development of major maternal complications, non-reassuring cardiotocography |
Glucocorticoid (betamethasone 12 mg in 2 doses); antihypertensive (dihydralazine and/or oral medication: methyldopa, nifidipine, or a combination); magnesium sulfate prophylaxis was not considered |
Immediate delivery with or without the administration of glucocorticoid |
Maternal death, eclampsia, HELLP syndrome, stillbirth, neonatal death, intraventricular hemorrhage, small-for-gestational age newborn |
Cesarean section, pulmonary edema, renal failure, hyaline membrane disease, birth weight |
Kumar et al.
(2011)
2222 Kumar M, Meena J, Gupta U, Singh A, Jain N. Management of early onset severe preeclampsia in a tertiary hospital in India: does expectant management alter perinatal outcome? Indian J Med Sci. 2011;65(12):535-542. Doi: 10.4103/0019-5359.109903 https://doi.org/10.4103/0019-5359.109903...
|
Retrospective non-randomized controlled study |
India |
106 |
25 years |
32 weeks |
Inclusion: blood pressure ≥ 160/110 mmHg and proteinuria > 5 g in a 24-hour urine specimen, or ≥ 3 + , or symptoms of impending preeclampsia; exclusion: not mentioned |
Glucocorticoid; oral antihypertensive drugs; fetal monitoring with ultrasound and Doppler study |
Immediate delivery with or without the administration of glucocorticoid |
Maternal death, eclampsia, HELLP syndrome, placental abruption, stillbirth, neonatal death, intraventricular hemorrhage, Small-for-gestational age newborn |
Cesarean section, pulmonary edema, birth weight, NICU admission |
Suzuki et al. (2014)
2323 Suzuki S, ShimadaM, Shibata-Hiraizumi Y. Clinical trial of expectant management of severe preeclampsia that develops at <32 weeks' gestation at a Japanese perinatal center. JMatern Fetal NeonatalMed. 2014;27(15):1568-1571. Doi: 10.3109/14767058.2013.870548 https://doi.org/10.3109/14767058.2013.87...
|
Retrospective non-randomized controlled study |
Japan |
49 |
34 years |
29 weeks |
Inclusion: early-onset severe preeclampsia; exclusion: patients with chronic hypertension, renal disease, and systemic illnesses |
Glucocorticoid (betamethasone 12 mg/day for 2 days); magnesium sulfate |
Immediate delivery with or without the administration of glucocorticoid |
HELLP syndrome, placental abruption, stillbirth, small-for-gestational age newborn |
Cesarean section, pulmonary edema, hyaline membrane disease, birth weight |
Ertekin et al. (2015)
2424 Ertekin AA, Kapudere B, Eken MK, Ilhan G, Dirman S, Sargin MA, et al. Does aggressive and expectant management of severe preeclampsia affect the neurologic development of the infant? Int J Clin Exp Med. 2015;8(10):19325-19331
|
Prospective non-randomized controlled study |
Turkey |
70 |
27 years |
31 weeks |
Inclusion: severe preeclampsia between 27 and 34 weeks of gestation; exclusion: multiple pregnancies |
Glucocorticoid (betamethasone 12 mg/12 hours in 2 doses); magnesium sulfate; antihypertensive drugs |
Initial management similar to intervention, but delivery in 24 hours of first dose of glucocorticoid |
HELLP syndrome, neonatal death, intraventricular hemorrhage, small-for-gestational age newborn |
Renal failure, low Apgar score at five minutes, hyaline membrane disease |
Rendón-Becerra e Ortiz-Martínez (2016)
2525 Rendón-Becerra CA, Ortiz-Martínez RA. Comparación de dos protocolos de manejo en preeclampsia severa, lejos del término, y resultados maternos y neonatales: una cohorte histórica Hospital Universitario San José, Popayán (Colombia). Rev Colomb Obstet Ginecol. 2016;67(01):26-5
|
Retrospective non-randomized controlled study |
Colombia |
100 |
26 years |
32 weeks |
Inclusion: singleton pregnancies at 24 and 34 weeks; exclusion: patients with eclampsia, HELLP syndrome, placental abruption, or fetal distress |
Glucocorticoid (betamethasone 12 mg/day for 2 days);magnesium sulfate; antihypertensive (labetalol and nifedipine); fetal monitoring |
Initial management similar to intervention, but delivery in 24–72 hours of the administration of glucocorticoid |
Maternal death, eclampsia, HELLP syndrome, placental abruption, neonatal death, intraventricular hemorrhage, small-for-gestational age newborn |
Pulmonary edema, renal failure, low Apgar score at five minutes, hyaline membrane disease |